Study guide

16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault

Key Takeaways Explain This Topic AI

Basson's circular model describes responsive desire that emerges after arousal rather than before it, while DSM-5-TR sexual dysfunctions require at least 6 months of symptoms with clinically significant distress.

SSRIs are the most common pharmacologic cause of sexual dysfunction, managed by dose reduction, switching to bupropion or mirtazapine, or adding bupropion.

Doxy-PEP is recommended by CDC for men who have sex with men and transgender women with a recent bacterial STI, and is not recommended for cisgender women.

After sexual assault, forensic evidence can generally be collected up to 5 days, prophylaxis is ceftriaxone 500 mg intramuscularly plus doxycycline for 7 days with metronidazole as indicated, and HIV nPEP must start within 72 hours.

Sexual orientation, sexual behavior, and gender identity are three independent variables; screening follows anatomy and behavior rather than identity, and the two-step gender question identifies transgender and non-binary patients far more reliably than a single question.

Last updated: September 2026

Taking a Sexual History That Actually Works

The blueprint asks the midwife to evaluate for concerns related to sex drive and sexual satisfaction , provide counseling for sexual concerns , assess for high-risk sexual behavior , and provide counseling and support following sexual assault . All four begin with a history that patients can answer honestly.

Ask permission and normalize: "I ask all my patients about sexual health because it affects so much else. Is that okay?"

Do not assume partner gender, relationship structure, what acts are involved, or which anatomy is used. Ask.

Use the 5 Ps — partners, practices, protection from STIs, past history of STIs, and pregnancy intention — and add a sixth P for pleasure : "Is sex comfortable and satisfying for you?"

Ask about pain , desire , arousal , orgasm , and satisfaction separately; patients report only what they are asked about.

Desire, Arousal and Sexual Function

The older linear model (Masters and Johnson: desire → arousal → orgasm → resolution) describes some encounters but not most. Basson's circular model recognizes responsive desire — beginning from emotional intimacy and sexual neutrality, with desire emerging after arousal rather than before it. This is normal , especially in long-term relationships and postpartum, and telling a patient so is often the entire intervention.

A desire discrepancy between partners is a relationship phenomenon, not a diagnosis.

DSM-5-TR Sexual Dysfunctions

Diagnosis Core Feature

Female Sexual Interest/Arousal Disorder Reduced or absent interest, erotic thoughts, initiation, excitement, or genital sensation

Female Orgasmic Disorder Marked delay, infrequency, absence, or reduced intensity of orgasm

Genito-Pelvic Pain/Penetration Disorder Difficulty with penetration, vulvovaginal or pelvic pain, fear of pain, or pelvic floor tightening

Each requires symptoms for at least 6 months , clinically significant distress , and that the problem is not better explained by severe relationship distress, another condition, or a substance or medication.

Common and Correctable Contributors

Medications: SSRIs are the single most common pharmacologic cause; options are dose reduction, switching to bupropion or mirtazapine, or adding bupropion. Also consider combined hormonal contraception (raises sex hormone binding globulin), opioids, beta blockers, and antihistamines.

Hypoestrogenism of lactation or menopause, producing genitourinary syndrome — treat with lubricant, moisturizer, and low-dose vaginal estrogen .

Pelvic floor hypertonicity , endometriosis, prior perineal trauma, and vulvodynia — refer for pelvic floor physical therapy .

Body image, fatigue and infant care demands, chronic illness, and history of trauma.

The PLISSIT Framework

Most sexual concerns are handled at the first two levels: P ermission (validating the concern), L imited I nformation (accurate education), S pecific S uggestions (lubricant, positions, timing, pelvic floor therapy, medication change), and I ntensive T herapy (referral to an AASECT-certified sex therapist).

Two FDA-approved medications exist for hypoactive sexual desire in premenopausal women: flibanserin , taken nightly and carrying hypotension and syncope warnings with alcohol and CYP3A4 inhibitors, and bremelanotide , a subcutaneous as-needed injection whose commonest effect is nausea.

Assessing High-Risk Sexual Behavior and Offering Prevention

Assess number and concurrency of partners, condom use, transactional sex, injection drug use, a partner's known risk or HIV status, and prior STIs — and respond with prevention rather than judgment.

PrEP: the CDC recommends that HIV pre-exposure prophylaxis be discussed with all sexually active adolescents and adults , and prescribed to anyone who requests it. Options include daily oral tenofovir-based regimens and long-acting injectable cabotegravir.

Doxy-PEP: doxycycline 200 mg taken within 72 hours of condomless sex reduces bacterial STIs and is recommended by CDC for men who have sex with men and transgender women with a bacterial STI in the past 12 months. It is not recommended for cisgender women , where trial data did not demonstrate benefit.

Vaccination: HPV, hepatitis A and B.

Expedited partner therapy where state law permits, and routine screening per CDC intervals.

Care After Sexual Assault

The midwife's first job is to make the encounter the opposite of the assault: the patient controls every step .

Immediate Priorities, in Order

Safety and medical stabilization. Treat injuries first; assess for strangulation, which carries delayed airway and neurologic risk and is a strong predictor of future homicide.

Consent to each component separately — history, examination, evidence collection, photographs, testing, and reporting are all distinct, and the patient may accept any and decline any.

Involve a SANE (Sexual Assault Nurse Examiner) or SAFE program when available; they have specific training and better forensic outcomes. Offer a victim advocate and the National Sexual Assault Hotline ( 800-656-HOPE ).

Forensic evidence can generally be collected up to 5 days (120 hours) after the assault, with jurisdictional variation. In most states a patient may have an examination and store a kit without reporting to law enforcement .

Prophylaxis and Testing

Intervention Detail

Emergency contraception Levonorgestrel or ulipristal, or a copper IUD up to 5 days — offer to every patient at risk of pregnancy

Bacterial STI prophylaxis Ceftriaxone 500 mg IM plus doxycycline 100 mg orally twice daily for 7 days , adding metronidazole 500 mg twice daily for 7 days where trichomoniasis is a concern

  • HIV nPEP Risk-assess and, if indicated, start a 28-day regimen within 72 hours — the sooner the better
  • Hepatitis B Vaccinate if unvaccinated; add HBIG for a known HBsAg-positive assailant
  • HPV Vaccinate if age-eligible
  • Baseline testing Pregnancy test, HIV, syphilis, hepatitis B and C, and NAAT for gonorrhea and chlamydia
  • Trauma-Informed Technique and Follow-Up

Explain every step before doing it, offer a support person, let the patient undress and redress privately, keep the door and your questions predictable, and stop immediately on request . Avoid unnecessary lithotomy positioning and narrate what you are doing.

Arrange follow-up at 1 to 2 weeks and again at 1 to 3 months , repeating STI testing and screening for post-traumatic stress, depression, and substance use . Know your state's mandatory reporting rules, which commonly cover minors and vulnerable adults and sometimes injuries, and tell the patient in advance what you are required to report — before she discloses, not after.

Collecting Sexual Orientation and Gender Identity (SOGI)

The blueprint separately lists "asks about sexual orientation," "asks about gender identity," and "provides care to non-binary individuals." These are data-collection and care-delivery tasks, not optional sensitivities.

Ask, do not infer. Sexual orientation (who a person is attracted to), sexual behavior (what they do and with whom), and gender identity are three independent variables . A patient may identify as a lesbian and have sex with men; a transgender man may need cervical cancer screening. Screening decisions follow anatomy and behavior , not identity labels.

Collect SOGI routinely , on intake forms and verbally, with a two-step gender question — current gender identity (including a write-in and a non-binary option) and sex assigned at birth — because the two-step method identifies transgender and non-binary patients far more reliably than a single question.

Explain why you are asking and how the information will be recorded, and ask what name and pronouns to use in the room, in the chart, and in front of family , which may differ.

Non-binary patients are not a subset of transgender men or women. Ask what words they use for their own body parts and use those words during the examination; take an organ inventory rather than assuming which organs are present; and confirm before documenting anything that could out them.

Record name and pronouns in the chart where other clinicians will see them, and correct the record — and yourself — without making the patient manage your discomfort.